- Andreas Bergthaler Group
- Christoph Binder Group
- Christoph Bock Group
- Sylvia Knapp Group
- Robert Kralovics Group
- Stefan Kubicek Group
- Joanna I. Loizou Group
- Jörg Menche Group
- Giulio Superti-Furga Group
- Georg Winter Group
- Chemical Screening, Proteomics and Metabolomics Facility
- Biomedical Sequencing Facility (BSF)
- Keiryn Bennett (Senior Researcher on Leave)
- Denise P. Barlow (retired in 2015)
The CeMM Proteomics and Metabolomics Facility has been designed to the highest standards with individual cubicles per machine, maintaining a constant temperature with minimal variation. State of the art resources include six liquid chromatography - mass spectrometry systems (including an Orbitrap Fusion Lumos), the infrastructure for optimally preparing proteomics and metabolomics samples for highest sensitivity detection and the computational infrastructure for comprehensive data analysis.
Established workflows enable the determination of protein-protein interactions, drug-protein interactions, quantitative expression proteomes, post-translational modifications in cell signalling pathways, and key cellular metabolites.